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Background: Hemophilia is a potentially disabling condition as hemophilic arthropathy develops early in life 
and is progressive, especially in patients treated in an on-demand regime. 
Objective: This study aimed to describe the structural joint status and the functional independence score of 
hemophiliac adults and correlate structural damage with the functional deficits found in these patients.
Methods: Hemophiliacs at the Juiz de Fora Regional Blood Center – HEMOMINAS Foundation, aged 18 years 
and over and treated in an on-demand regime, were clinically evaluated in respect to structural joint damage 
using the World Federation of Hemophilia Physical Examination Scale (WFH-PE) and functional deficits using 
the Functional Independence Score in Hemophilia (FISH). The Spearman rank test was used to evaluate the 
correlation between the two scores.
Results: Thirty-nine patients were evaluated. The mean age was 36.8 years. Target joints were detected in 
69.2% of patients studied. The mean Physical Examination Scale and Functional Independence Score were 
16.87 and 25.64, respectively. Patients with mild hemophilia showed no significant joint involvement. Patients 
with severe or moderate hemophilia had similar results regarding structural damage (p-value < 0.001) and 
functional deficits (p-value = 0.001). There was statistical significance in the correlation between the two scores 
(r = -0.850; p-value = 0.01).
Conclusions: The World Federation of Hemophilia Physical Examination Scale and Functional Independence 
Score in Hemophilia may be useful to clinically assess structural joint damage and functional deficits 
in hemophiliacs as the tools are inexpensive and easy to administer and may be able to detect hemophilic 
arthropathy, which results from recurrent hemarthrosis and is common in the population studied. 
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Introduction
Hereditary hemophilia is the result of genetic alterations that cause deficiencies in 
clotting factors VIII or IX, hindering the process of hemostasis and predisposing hemophiliacs 
to spontaneous or post-traumatic bleeding. The main clinical manifestation is intra-articular 
bleeding (hemarthrosis), which begins even in childhood(1-3). After an episode of hemarthrosis 
the joint can return to its normal functional state. However commonly there is a recurrence 
of bleeding, causing inflammatory and enzymatic changes in the synovial membrane(4). The 
joints evolve to a state of fibrosis and contracture, with loss of mobility(5), causing deformities 
and disabilities in patients even within the first decades of life(6).
The treatment of hemophilia is based on the intravenous replacement of the deficient 
clotting factors. Infusions can be administered as prophylaxis, preventing bleeding episodes and 
reducing the incidence of arthropathies(7-10), or on demand, i.e., after each bleeding episode. Due 
to the high cost of clotting factor products, only in late 2011 did the Ministry of Health announce 
the implementation of primary prophylaxis in Brazil, benefiting children up to 36 months of age 
with severe hemophilia (or moderate, with a level of clotting factor VIII or IX less than 2%)(11).
Since, under the episodic treatment regime, the development of arthropathy seems 
inexorable(6,12), rehabilitation measures and methods to assess the clinical condition of the joints 
are essential to monitor the progression of the arthropathy, to establish or modify treatment 
protocols, and to assess the effectiveness of therapeutic interventions(13-15). In this context, 
the present study aimed to clinically evaluate the major joints of adults with hemophilia with 
regard to structural damage and functional deficits, and to correlate these findings.
Methods
Study design and data collection 
This was an observational, cross-sectional study, conducted at the HEMOMINAS 
Foundation, Regional Blood Center of Juiz de Fora (HRJF), Minas Gerais after approval 
by the institution’s Research Ethics Committee. Informed consent was obtained from 
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all patients. The inclusion criteria were: male, aged 18 years 
or older, and a level of clotting factor VIII or IX less than or 
equal to 30%. Of the 60 patients eligible for the study, one was 
excluded before the start of the study due to severe cognitive 
impairment resulting from a central nervous system hemorrhage; 
13 were not located due to outdated records and seven refused 
to participate in the study. Thus, between June and November 
2011, 39 patients with hemophilia were evaluated, all treated 
under the on-demand protocol. 
For the purposes of this study, patients were interviewed 
about demographic and socioeconomic data (age, race, education, 
marital status, main occupation, personal and family income, 
receipt of social security benefits) and from medical records, data 
were collected on hemophilia and comorbidities (type and severity 
of hemophilia, presence of a clotting factor inhibitor, presence of 
infection with hepatitis B virus, hepatitis C, and human acquired 
immunodeficiency virus, target joints) and on the treatment of the 
coagulopathy (age at diagnosis, participation in the emergency 
home infusion program, physical activity habits, physical therapy 
and clotting factor consumption in the previous 12 months). 
Participants were evaluated according to the 
recommendations of the World Federation of Hemophilia 
(WFH). The WFH Physical Examination Score (WFH-PE) and 
the Functional Independence Score in Hemophilia (FISH) were 
applied by a single duly qualified examiner. 
World Federation of Hemophilia physical examination scale
This scale is an instrument developed in the 1980s to evaluate 
hemophilic arthropathy. It is still widely used(16) because it is easy 
to perform and capable of providing an extensive musculoskeletal 
assessment(4). A tape measure and a goniometer are used in 
the examination of the knees, ankles, elbows, and hips for the 
presence of edema, atrophy, crepitus, flexion contractures, axial 
deformities, loss of range of motion and instability; points are 
assigned to each finding, according to severity and are summed. 
A score of zero denotes normal joints; 68 points corresponds to 
the worst level of arthropathy(17,18).
Functional Independence Score in Hemophilia
This score was developed to measure the functional 
independence of people with hemophilia. FISH is based on 
observing the performance of daily life activities. Patients are 
assessed for their ability to perform eight tasks, divided into 
three categories: self-care (eating, grooming, bathing and 
dressing), transfers (chair and squatting) and mobility (walking, 
going up stairs and running). The activities were clearly defined 
by the authors of the instrument to reduce inter-observer 
variance and graded from 1 to 4, according to the assistance 
required to perform the task as follows: 1) the individual is 
unable to perform the activity; 2) assistance or adaptation 
is needed to perform the activity; 3) the activity is performed, but 
the individual has discomfort; and 4) the activity is performed 
normally. The scores achieved in each task are summed giving a 
total from 8 to 32 points with 32 indicating the highest level of 
functional independence(19,20).
The purpose of including ‘running’ was to increase the detection 
capabilities of the assessment tool, especially for patients with less 
severe joint damage(20). However, in this study carried out at the 
HRJF, it was not possible to assess the participant’s capacity to run 
as the examination was performed in a doctor’s office. In an attempt 
to compensate for this obstacle, patients were shown an expanse of 
50 meters in the area outside the blood center, and were asked if they 
could cross it running, presenting them the four performance options 
described in the tool. The patients responded without hesitation.
Statistical analysis
Initially, the Kolmogorov-Smirnov test with Lilliefors 
correction was performed, which revealed the non-normality of 
the data. So the non-parametric Mann-Whitney U test was applied 
to compare the mean WFH-PE and FISH scores according to 
the severity of hemophilia. Spearman correlation analyses were 
conducted to evaluate the relationship between WFH-PE, FISH, 
patient age, and consumption of clotting concentrate in the previous 
12 months. Statistical analysis was performed using the Statistical 
Package for the Social Sciences (SPSS, version 15) program.
Results
Thirty-nine patients were evaluated. Participant ages ranged 
from 18 to 79 years [mean = 36.8; standard deviation (SD) = 16.8 
years]. Other demographic and socioeconomic characteristics of 
the patients are shown in Table 1.
Table 1 - Demographic and socioeconomic characteristics of patients
with hemophilia at the Regional Blood Center of Juiz de Fora
Variable n %
Age
18 to 29 years 17 43.6
30 to 59 years 17 43.6
60 years or over 5 12.8
Self-reported skin color
White 23 59.0
Brown/ light-brown/ mulatto 11 28.2
Black 3 7.7
Indigenous 2 5.1
Distance between home and blood center
0 to 30 km 18 46.2
More than 30 km 21 53.8
Schooling
0 to 4 years 9 23.1
5 to 8 years 9 23.1
9 to 11 years 14 35.9
12 years or more 7 17.9
Occupation*
Student 13
Employed formally / informally 11
Retired (age or due to illness) 24
Without declared occupation 1
Social security benefits due to hemophilia
Yes 20 51.3
No 19 48.7
*some patients belonged to two or more groups.
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Patient health conditions and characteristics of the 
treatment received
Of the 39 participants, 33 had hemophilia A and 6 had 
hemophilia B. In eight cases (20.5%) the hemophilia was 
classified as mild (level of factor VIII or IX between 5 and 30%), 
in 16 (41%) as moderate hemophilia (level of factor VIII or IX 
between 1 and 5%) and in 15 cases (38.5%) as severe hemophilia 
(level of factor VIII or IX < 1%). 
Age at diagnosis ranged from 0 to 67 years with the 
diagnosis being made after three years of life in 58.8% of the 
cases. Comorbidities reported by patients were: asthma (10.3%), 
arthritis (2.6%), cancer (2.6%), heart disease (2.6%), depression 
(12.8%), hypertension (17.9%), chronic lower back pain (15.4%) 
and smoking (28.9%); 66.7% were considered sedentary and 
15.4% had a body mass index greater than 25 kg/m2.
The records of four patients (10.5%) registered seropositive 
for human immunodeficiency virus (HIV), 22 (57.9%) for 
hepatitis B virus (HBV), and 22 (57.9%) for hepatitis C virus 
(HCV). Of 29 participants who had up-to-date test records, the 
presence of clotting factor inhibitor was detected in only one 
patient with hemophilia A and in no patients with hemophilia B.
Among the 33 patients with hemophilia A, the consumption 
of clotting factor VIII concentrate in the previous 12 months 
was quite variable as shown in Table 2. Of the 31 patients with 
severe or moderate hemophilia, 22 (70.96%) were participating 
in the home infusion program of clotting factor concentrates in 
emergency situations.
The mean WFH-PE score was 16.87 (standard 
deviation 9.49). Table 3 presents the clinical findings in 
the joints assessed using the WFH-PE scale. Patients with 
mild hemophilia showed no resulting joint damage from 
hemophilia. Three of them (18.75%) were scored only on 
the crepitus on motion item, which, alone, is not indicative 
of hemophilic arthropathy. Table 4 shows the results of 
the evaluation using the WFH-PE scale according to the 
severity of hemophilia.
Table 2 - Consumption of factor VIII concentrate in patients with hemophilia 
A in the previous 12 months
Severity of hemophilia Consumption of factor VIII concentrate (IU)
Minimum Maximum Mean
Mild (n = 7) 0 25,500 4,321.43
Moderate (n = 14) 0 198,250 51,625.00
Severe (n = 12) 14,750 174,250 63,683.33
IU: international units
Clinical evaluation of structural joint status and 
functional independence
In 69.2% of the patients, target joint presence was detected 
(87.1% of the patients with severe or moderate forms of 
coagulopathy), which indicates, at least, the first stage of hemophilic 
arthropathy(5). However, only eight participants in this study (20.5%) 
had received physiotherapy sessions in the previous 12 months even 
though the benefits of physical therapy for the rehabilitation of these 
patients have been demonstrated(11). When the other 31 participants 
were asked about the reasons that led them not to seek physiotherapy, 
16 (51.6%) considered the approach unnecessary, four (12.9%) 
believed that physical therapy could worsen the joint symptoms, 
another four said they did not have free access to a physiotherapy 
service in the area where they lived, two (6.45%) claimed that there 
had been no medical recommendation and five patients (16.1%) 
cited other reasons or did not know how to respond.
Table 4 - Joint assessment using the World Federation of Hemophilia 
Physical Examination Scale (WFH-PE) by severity of hemophilia
Severity of hemophilia Validn Minimum Maximum Mean
Standard 
deviation
Severe 15 15 34 20.67 6.70
Moderate 16 4 29 20.19 7.54
Mild 8 1 6 3.13 1.72
Total 39 1 34 16.87 9.49
There was no statistically significant difference in the mean 
WFH-PE scores between patients with moderate and severe 
hemophilia (15.47 vs. 16.50; p-value = 0.752) but there was a 
significant difference when comparing the average scores achieved 
in the structural joint damage assessments of patients with mild 
hemophilia to the average of the other patients (4.81 vs. 23.92; 
p-value < 0.001).
The score of the WFH-PE tool showed significant 
statistical correlation with the age of the patients with 
moderate (r = 0.51; p-value = 0.04) or severe (r = 0.54; p-value 
= 0.03) hemophilia, but not with the age of the patients with 
mild hemophilia (r = 0.41; p-value = 0.30), nor with the 
consumption of clotting factor in the previous 12 months 
regardless of the severity of hemophilia.
The mean score of the FISH instrument was 25.64 
(SD: 6.09). Seven out of eight patients with mild hemophilia 
achieved the maximum functional independence score. Only one 
elderly patient reported that he would find running and bathing 
uncomfortable. Additional results from the FISH assessment are 
shown in Tables 5 & 6.
There was no statistically significant difference 
between patients with severe and moderate hemophilia in 
terms of the mean functional independence score (16.37 
vs. 15.66; p-value = 0.827), yet the assessment results for 
patients with mild hemophilia were significantly better when 
compared to those of the other participants (32.25 vs. 16.84; 
p-value = 0.001).
FISH showed a good correlation with the age of 
patients with severe (r = -0.63; p-value = 0.01) and 
moderate (r = -0.55; p-value = 0.02) hemophilia, but not 
with the age of patients with mild hemophilia (r = -0.08; 
p-value = 0.84) nor with the consumption of clotting factor 
concentrate in the previous 12 months regardless of the 
severity of hemophilia.
The Spearman correlation coefficient between the WFH-PE 
and FISH scores was -0.850 (p-value = 0.01).
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Discussion 
The WFH-PE and FISH assessment instruments proved 
useful in the clinical evaluation of structural joint status and 
functional independence of adults with hemophilia. Both are 
easily performed, inexpensive and able to detect the principle 
types of damage caused by recurrent hemarthrosis, which is quite 
evident in the population of this study.
Of the 31 patients with severe or moderate hemophilia, 27 
(87.1%) showed at least the first stage of hemophilic arthropathy(5) 
and 20 (64.5%) were dependent on social security benefits due 
to complications from hemophilia, although the average age of 
this subgroup was only 35.1 years. Twenty-two patients (70.9%) 
participated in the home infusion program, indicating reasonable 
coverage by the program, as an attempt to minimize the 
inconvenience caused by transferring patients to the blood center.
It is noted that physical therapy, in general, is not viewed 
by patients as an integral part of coagulopathy treatment. They 
consider it necessary only in extreme circumstances such as injuries 
that cause acute immobility. Thus, disabilities that set in gradually 
continue to be neglected by the patients themselves, and, unlike 
what was shown in an audit by the Brazilian Court of Audit(21), 
it was not difficulty to access rehabilitation services that was 
primarily responsible for this lapse in treatment of HRJF patients, 
but the lack of information about the importance of physiotherapy 
in the prevention or treatment of injuries.
Among patients with mild hemophilia who do not generally 
exhibit spontaneous hemarthrosis, no significant change in the 
joint structure or functional clinical assessment was seen. What 
is noteworthy is that the structural joint damage and functional 
disabilities in patients with severe hemophilia and in those with 
moderate hemophilia are very similar. In 2011, Den Uijl et al. 
demonstrated the high clinical variability in this latter group of 
patients(22) which was corroborated in this study not only by the 
clinical findings but also by the variability in the consumption of 
clotting factor concentrate. This variability in the consumption 
of blood products among patients with coagulopathies of equal 
severity was so high that possible explanations extend beyond the 
medical field, extrapolating to psychological or accessibility issues. 
The assessment of joint conditions of patients who had consumed 
larger amounts of blood products in the previous 12 months was 
also quite variable and no cause-effect relationship between the 
factor ‘consumption of blood products’ and severity of arthropathy 
can be suggested as this was a cross-sectional study.
 
Conclusion
The WFH-PE and FISH instruments may be extremely useful 
in the clinical practice in the absence of imaging exams such as 
magnetic resonance imaging (MRI), which are considered very 
sensitive to detect early joint damage, but at a cost that makes 
them relatively inaccessible.
Table 5 - Assessment of functional independence of patients with hemophilia 
Activities
Functional Independence Score in Hemophilia
n (%)
1 2 3 4
Eating and grooming 0 3 (7.7) 2 (5.1) 34 (87.2)
Bathing 0 3 (7.7) 8 (20.5) 28 (71.8)
Dressing 0 13 (33.3) 2 (5.1) 24 (61.6)
Transfers – sitting 0 12 (30.8) 4 (10.2) 23 (59.0)
Transfers – squatting 16 (41.0) 1 (25.6) 6 (15.4) 16 (41.0)
Going up a step 0 14 (35.9) 5 (12.8) 20 (51.3)
Walking 0 4 (10.2) 18 (46.2) 17 (43.6)
Running 15 (38.5) 3 (7.7) 4 (10.2) 17 (43.6)
Scores from 1 to 4 in each area:
1. The subject is unable to perform the activity, or needs complete assistance to perform the activity
2. The subject needs partial assistance/aids/modified instruments/modified environment to perform 
the activity
3. The subject is able to perform the activity without aids or assistance, but with slight discomfort. He 
is unable to perform the activity similar to his healthy peers
4. The subject is able to perform the activity without any difficulty similar to his healthy peers
Table 6 - Functional Independence Score in Hemophilia by severity of hemophilia
Severity of hemophilia Validn Minimum Maximum Mean
Standard 
deviation
Severe 15 14 32 24.20 6.10
Moderate 16 16 32 23.94 5.74
Mild 8 30 32 31.75 1.72
Total 39 14 32 25.64 6.09
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The prevalence of clinically detected joint structural 
lesions is high, as are deficits that impair functional 
independence in patients with severe or moderate forms of 
hemophilia at the HRJF.
Pending the implementation of primary prophylaxis in 
Brazil, the diagnosis of coagulopathies early in life becomes 
imperative. Due to the severity of arthropathies found in patients 
with moderate hemophilia, it is suggested that these individuals 
should be evaluated in a personalized way with respect to the 
more precise and accurate laboratory classification of the severity 
of hemophilia, to facilitate the recommendation of appropriate 
prophylaxis for these children. 
For adults and adolescents (the latter not included in this 
study, but also not benefiting from proposed prophylaxis) there is 
current relevance in the guidelines regarding measures to prevent 
joint damage and on the fundamental importance of rehabilitation 
measures aimed at social reinsertion. 
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